Back
Bruker 10K Form
Sell
28
BRKR
Bruker
Last Price:
54.51
Seasonality Move:
5.54%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-10 | 10Q | BRKR/Bruker Quarterly |
| 2024-02-29 | 10K | BRKR/Bruker Annual |
| 2023-11-09 | 10Q | BRKR/Bruker Quarterly |
| 2023-08-09 | 10Q | BRKR/Bruker Quarterly |
| 2023-05-10 | 10Q | BRKR/Bruker Quarterly |
| 2023-03-01 | 10K | BRKR/Bruker Annual |
Receive BRKR News And Ratings
See the #1 stock for the next 7 days that we like better than BRKR
BRKR Financial Statistics
Sales & Book Value
| Annual Sales: | $2.96B |
|---|---|
| Cash Flow: | $5.8M |
| Price / Cash Flow: | 52.93 |
| Annual Sales: | $11.92 |
| Price / Book: | 4.7 |
Profitability
| EPS (TTM): | 2.08000 |
|---|---|
| Net Income (TTM): | $304.9M |
| Gross Margin: | $1.51B |
| Return on Equity: | 19.61% |
| Return on Assets: | 6.2% |
Bruker Earnings Forecast
Key Bruker Financial Ratios
- The Gross Profit Margin over the past 25 years for BRKR is 51.05%.
- The Selling, General & Administrative Expenses for BRKR have been equal to 24.63% of Gross Profit Margin.
- The Research & Development expenses have been 9.94% of Revenue.
- The Interest Expense is 3.84% of Operating Income.
- The Net Earning history of BRKR is 14.41% of Total Revenues.
- Per Share Earnings over the last 25 years have been positive in 15 years.
Bruker Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | BRKR |
| CUSIP: | 116794 |
| Website: | bruker.com |
Debt
| Debt-to-Equity Ratio: | 1.27 |
|---|---|
| Current Ratio: | 1.66 |
| Quick Ratio: | 0.65 |
Price-to-Earnings
| Trailing P/E Ratio: | 19.32 |
|---|---|
| Forward P/E Ratio: | 20.35 |